Comparative response in growth and bone status to three dexamethasone treatment regimens in infant piglets

Pediatric Research

Volumn 48, Issue 2, 2000, Pages 238-243

  Guo, Chun Yuan ^a   Ward, Wendy ^a   Cairns, Pamela ^a   Atkinson, Stephanie ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; OSTEOCALCIN;

ARTICLE; AUTOPSY; BONE MINERALIZATION; BONE TURNOVER; CHILD GROWTH; CHRONIC LUNG DISEASE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOSE RESPONSE; GROWTH RETARDATION; HUMAN; MALE; NEWBORN; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; SWINE;

EID: 0033930719     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200008000-00019     Document Type: Article

References (39)

1. Bronchopulmonary dysplasia: Then and now
2. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation
3. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia
4. Longitudinal assessment of growth and bone mineral accretion in prematurely born infants treated for chronic lung disease with dexamethasone
5. Catabolic effect of dexamethasone in the preterm baby
6. Growth retardation after dexamethasone administration: Assessment by knemometry
7. Bone metabolism and circulating IGF-I and IGFBPs in dexamethasone-treated preterm infants
8. Dexamethasone therapy in neonatal chronic lung disease: An international placebo-controlled trial
9. Corticosteroid and chronic lung disease in extremely immature infants: A dilemma
10. Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease
11. The pig as a model for human nutrition
12. Dexamethasone-induced abnormalities in growth and bone metabolism in piglets are partially attenuated by growth hormone with no synergistic effect of insulin-like growth factor-I
13. Dexamethasone treatment impairs calcium regulation and reduces bone mineralization in infant pigs
14. A multi-element isotopic tracer assessment of true fractional absorption of minerals from formula with additives of calcium, phosphorus, zinc, copper and iron in young piglets
15. Corticosteroid-induced osteoporosis
16. Management of corticosteroid-induced osteoporosis
17. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children
18. Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentration and urinary deoxypyridinoline excretion: Effects of growth and aging
19. Guide for the care and use of experimental animals
20. Calcium-regulating hormones, bone mineral content, breaking load and trabecular remodeling are altered in growing pigs fed calcium-deficient diets
21. Mineral bioavailability and bone mineral contents in pigs given calcium carbonate postprandially
22. Improvement in the accuracy of dual energy x-ray absorptiometry for whole body and regional analysis of body composition: Validation using piglets and methodological considerations in infants
23. Inhibition of the morning cortisol peak abolishes the expected morning decrease in serum osteocalcin in normal males: Evidence of a controlling effect of serum cortisol on the circadian rhythm in serum osteocalcin
24. Relations between diurnal variations in serum osteocalcin, cortisol, parathyroid hormone, and ionized calcium in normal individuals
25. Diurnal rhythm and 24-hour integrated concentrations of serum osteocalcin in normal: Influence on age, sex, season and smoking habits
26. Diurnal rhythm in serum osteocalcin: Relation with sleep, growth hormone, and PTH(1-84)
27. Longitudinal evaluation of the development of salivary cortisol circadian rhythm in infancy
28. Pituitary-adrenal suppression and recovery in preterm very low birth weight infants after dexamethasone treatment for bronchopulmonary dysplasia
29. Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism
30. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects
31. Assessment of systemic effects of inhaled glucocorticosteroids; comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover
32. Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids
33. Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin
34. Bone turnover during high dose inhaled corticosteroids treatment
35. Growth hormone and insulin-like growth factor-I therapy promote protein deposition and growth in dexamethasone-treated piglets
36. Glucocorticoid effects on bone. [Editorial]
37. New developments in the pathogenesis and treatment of steroid-induced osteoporosis
38. Intact parathyroid hormone levels are elevated in infant piglets receiving oral chronic glucocorticoids for 2 weeks